Dr.whitiss 15%
NDC Package 47649-1102-2
Package Information
Dr.whitiss 15% is a . Marketed by Nibec Co., Ltd., this product is identified by NDC 47649-1102 and is authorized under FDA application part356.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 47649 - Nibec Co., Ltd.
- 47649-1102 - Dr.whitiss 15%
- 47649-1102-2 - 4 SYRINGE in 1 PACKAGE / 1 g in 1 SYRINGE (47649-1102-1)
- 47649-1102 - Dr.whitiss 15%
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 47649-1102-2 identifies a specific commercial package of 4 syringe in 1 package / 1 g in 1 syringe (47649-1102-1) of Dr.whitiss 15%, labeled by Nibec Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Nibec Co., Ltd. on June 07, 2015. The current certification is valid through December 31, 2022.
How is this Nibec Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 47649110202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.